Form D · Other Technology

Strategic Pharmaceutical Solutions, Inc

Portland, OR · CIK 0001365077

Offering snapshot reported Mar 15, 2018 · SEC filing

Reported sold
$1.49M
Offering amount: $3M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 2, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2018Initial$1,492,758No comparison2SEC filing
May 31, 2016Initial$1,870,738No comparison1SEC filing
Oct 29, 2015Initial$9,975,584No comparison1SEC filing
Apr 20, 2010Initial$10,000,000No comparison1SEC filing
Sep 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 15, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-307845

Source: Form D, filed Mar 15, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott Anderson Director
Bob Antin Director
Jim Cleary Director
Greg Colvin Director
Doug Drew Director
Steve Fisher Director
Thomas Friar Executive
Kurt Green Director, Executive
George Henriques Director
Doug Jones Director
David Laurance Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
17014 Ne Sandy Blvd.
Portland, OR, 97230